[Use of immunoglobulin for treating patients with nonspecific ulcerative colitis]. 1986

I L Khalif, and B V Kirkin, and I A Glad'ko, and V M Korshunov, and B V Pinegin

The therapeutic effect of human immunoglobulins was assessed in 29 patients with nonspecific ulcerative colitis, as was their influence on intestinal flora. A 5 to 15 ml dose of immunoglobulin was administered intramuscularly every other day, 3 injections altogether. The clinical and endoscopic effect of treatment was positive in 21 patients (72.4%). Large-intestinal mucosal imprints were studied histologically in 17 patients. Inflammation subsided in 11 patients (64.7%), and glandular epithelial proliferation declined in 4 (23.5%). In the course of treatment, lactobacilli, and bifidobacteria were considerably increased in number, while opportunity organisms were decreased, a possible cause of the positive clinical effect.

UI MeSH Term Description Entries
D007116 Immunization, Passive Transfer of immunity from immunized to non-immune host by administration of serum antibodies, or transplantation of lymphocytes (ADOPTIVE TRANSFER). Convalescent Plasma Therapy,Immunoglobulin Therapy,Immunotherapy, Passive,Normal Serum Globulin Therapy,Passive Antibody Transfer,Passive Transfer of Immunity,Serotherapy,Passive Immunotherapy,Therapy, Immunoglobulin,Antibody Transfer, Passive,Passive Immunization,Therapy, Convalescent Plasma,Transfer, Passive Antibody
D007422 Intestines The section of the alimentary canal from the STOMACH to the ANAL CANAL. It includes the LARGE INTESTINE and SMALL INTESTINE. Intestine
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D003093 Colitis, Ulcerative Inflammation of the COLON that is predominantly confined to the MUCOSA. Its major symptoms include DIARRHEA, rectal BLEEDING, the passage of MUCUS, and ABDOMINAL PAIN. Colitis Gravis,Idiopathic Proctocolitis,Inflammatory Bowel Disease, Ulcerative Colitis Type,Ulcerative Colitis
D005069 Evaluation Studies as Topic Works about studies that determine the effectiveness or value of processes, personnel, and equipment, or the material on conducting such studies. Critique,Evaluation Indexes,Evaluation Methodology,Evaluation Report,Evaluation Research,Methodology, Evaluation,Pre-Post Tests,Qualitative Evaluation,Quantitative Evaluation,Theoretical Effectiveness,Use-Effectiveness,Critiques,Effectiveness, Theoretical,Evaluation Methodologies,Evaluation Reports,Evaluation, Qualitative,Evaluation, Quantitative,Evaluations, Qualitative,Evaluations, Quantitative,Indexes, Evaluation,Methodologies, Evaluation,Pre Post Tests,Pre-Post Test,Qualitative Evaluations,Quantitative Evaluations,Report, Evaluation,Reports, Evaluation,Research, Evaluation,Test, Pre-Post,Tests, Pre-Post,Use Effectiveness
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001419 Bacteria One of the three domains of life (the others being Eukarya and ARCHAEA), also called Eubacteria. They are unicellular prokaryotic microorganisms which generally possess rigid cell walls, multiply by cell division, and exhibit three principal forms: round or coccal, rodlike or bacillary, and spiral or spirochetal. Bacteria can be classified by their response to OXYGEN: aerobic, anaerobic, or facultatively anaerobic; by the mode by which they obtain their energy: chemotrophy (via chemical reaction) or PHOTOTROPHY (via light reaction); for chemotrophs by their source of chemical energy: CHEMOLITHOTROPHY (from inorganic compounds) or chemoorganotrophy (from organic compounds); and by their source for CARBON; NITROGEN; etc.; HETEROTROPHY (from organic sources) or AUTOTROPHY (from CARBON DIOXIDE). They can also be classified by whether or not they stain (based on the structure of their CELL WALLS) with CRYSTAL VIOLET dye: gram-negative or gram-positive. Eubacteria

Related Publications

I L Khalif, and B V Kirkin, and I A Glad'ko, and V M Korshunov, and B V Pinegin
January 1975, Zhurnal eksperimental'noi i klinicheskoi meditsiny,
I L Khalif, and B V Kirkin, and I A Glad'ko, and V M Korshunov, and B V Pinegin
May 1969, Klinicheskaia meditsina,
I L Khalif, and B V Kirkin, and I A Glad'ko, and V M Korshunov, and B V Pinegin
May 1969, Fel'dsher i akusherka,
I L Khalif, and B V Kirkin, and I A Glad'ko, and V M Korshunov, and B V Pinegin
July 1971, Meditsinskaia sestra,
I L Khalif, and B V Kirkin, and I A Glad'ko, and V M Korshunov, and B V Pinegin
October 1962, Postgraduate medicine,
I L Khalif, and B V Kirkin, and I A Glad'ko, and V M Korshunov, and B V Pinegin
November 1969, Surgery,
I L Khalif, and B V Kirkin, and I A Glad'ko, and V M Korshunov, and B V Pinegin
March 1974, Sovetskaia meditsina,
I L Khalif, and B V Kirkin, and I A Glad'ko, and V M Korshunov, and B V Pinegin
February 1987, Meditsinskaia sestra,
I L Khalif, and B V Kirkin, and I A Glad'ko, and V M Korshunov, and B V Pinegin
January 1971, Vrachebnoe delo,
I L Khalif, and B V Kirkin, and I A Glad'ko, and V M Korshunov, and B V Pinegin
January 1995, Arquivos de gastroenterologia,
Copied contents to your clipboard!